Clinical Trial Update: Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether an SSRI can predict treatment responses in individuals with alcohol use disorder. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: University of Cincinnati | Conditions: Alcoholism, Alcohol Abuse | Phase 2 | Status: COMPLETED